The Medicines Company has announced the appointments of Bruce Rosengard and Sanuj Ravindran as vice presidents, new business ventures. Dr. Bruce Rosengard is a cardiothoracic surgeon who joins The Medicines Company from the Massachusetts General Hospital and Harvard Medical School, where he was the Surgical Director of Cardiac Transplantation and ran an NIH-funded laboratory in transplantation immunology. Dr. Sanuj Ravindran was most recently a Managing Director at Asian Healthcare Fund.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% | +0.14% | -0.05% |
2020 | The Medicines Company Announces Board Changes | CI |
2020 | The Medicines Company(NasdaqGS:MDCO) dropped from S&P 600 Health Care | CI |
1st Jan change | Capi. | |
---|---|---|
-0.05% | 6.79B | |
+20.39% | 43.67B | |
+26.21% | 22.79B | |
+21.43% | 15.45B | |
+18.82% | 14.29B | |
+53.37% | 12.83B | |
-11.88% | 6.52B | |
-8.87% | 5.73B | |
+12.62% | 5.59B | |
+9.77% | 4.73B |
- Stock Market
- Equities
- MDCO Stock
- News The Medicines Company
- The Medicines Company Announces Executive Appointments